Jeon Hwa-seong's Startup Morning Coffee #1031: Twinwiz - Envisioning Innovation and the Future
The YouTube program 'Startup Morning Coffee', hosted by CEO Jeon Hwa-sung, is broadcast live every day at 8:40 AM on the 'Jeon Hwa-sung's CNTV' channel, establishing itself as a vibrant platform for information exchange within the startup e...
The YouTube program 'Startup Morning Coffee', hosted by CEO Jeon Hwa-sung, is broadcast live every day at 8:40 AM on the 'Jeon Hwa-sung's CNTV' channel, establishing itself as a vibrant platform for information exchange within the startup ecosystem. This program deeply covers the core competencies and market potential of various startups, and through interactive communication with viewers via real-time comments, it effectively serves as a useful information platform.
One of the promising companies recently highlighted on this program is 'Twinwiz'. Twinwiz, a startup originating from the Korea Institute of Materials Science (KIMS), is leading technological innovation by developing liquid antiviral, antibacterial, and antifungal materials that overcome the limitations of existing solid-form materials. Their proprietary technology offers significant advantages: it can impart powerful antimicrobial functions without altering the color or appearance of the product, achieves excellent effects with only a small amount of additive, and provides antimicrobial and antiviral effects without requiring additional processing.
Twinwiz's liquid antiviral products have a very wide range of applications. In particular, they are actively pursuing sales efforts with the goal of entering the paint market, which is projected to grow to approximately 300 trillion won by 2040. They have already signed supply contracts with advanced materials companies and are expanding collaborations with leading firms such as Chokwang Paint and Sekyung Hitech, thereby strengthening their market position. Furthermore, Twinwiz is also gaining attention in the medical field by offering innovative medical solutions that can reduce infection rates during surgery by up to 50% through its antimicrobial suture technology. Currently, they are accelerating the commercialization of their technology by participating in CNTTech's KDB NextOne support program.
CEO Jeon Hwa-sung praised Twinwiz's technology and potential, stating, "Twinwiz, a startup from the Korea Institute of Materials Science, has attracted investments from various institutions such as KDB NextOne, KODIT, Gangnam Venture Investment, and Busan Federation of Technology Holdings, thereby earning recognition for its material technology." He expressed great anticipation for the positive ripple effects that their innovative material technology will bring across various industrial sectors in the future.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0